Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Asset disposition
Inv. presentation
Class action filed
Quarterly results
Credit agrmnt [a]
CC transcript
Appointed director

Symmetry Medical Inc. (SMA) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/08/2020 GN SMART Technologies Launches New Interactive Display with Revolutionary Platform - Bridging Physical and Digital Learning
11/25/2019 GN Bett announces global partnership with SMART Technologies
11/05/2019 GN SMART Updates Interactive Flat Panels with Unmatched Precision, Interaction and Performance
11/05/2019 GN SMART Updates Interactive Flat Panels with Unmatched Precision, Interaction and Performance
02/13/2015 SC 13G/A AMERIPRISE FINANCIAL INC reports a 0% stake in Symmetry Medical Inc.
02/12/2015 SC 13G/A FRONTIER CAPITAL MANAGEMENT CO LLC reports a 0% stake in SYMMETRY MEDICAL INC.
02/12/2015 SC 13G/A Boston Partners reports a 0% stake in Symmetry Medical Inc.
02/05/2015 SC 13G/A DIMENSIONAL FUND ADVISORS LP reports a 0% stake in SYMMETRY MEDICAL INC
12/17/2014 8-K Quarterly results
12/10/2014 SC 13G/A Moab Capital Partners LLC reports a 0% stake in SYMMETRY MEDICAL INC.
12/08/2014 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs: "Fifth Amended and Restated Certificate of Incorporation of Symmetry Medical Inc.",
"Second Amended and Restated Bylaws of Symmetry Medical Inc.",
"Second Amendment to Severance Agreement by and between Symmetry Medical Inc. and Fred L. Hite",
"Warsaw, Indiana, December 5, 2014"
12/04/2014 8-K Submission of Matters to a Vote of Security Holders
11/26/2014 8-K Other Events
11/26/2014 425 Form 425 - Prospectuses and communications, business combinations
11/20/2014 8-K Other Events
11/20/2014 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
11/18/2014 8-K Class action lawsuit filed
11/18/2014 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
11/07/2014 SC 13G/A BlackRock Inc. reports a 15.4% stake in SYMMETRY MEDICAL INC.
11/06/2014 10-Q Quarterly Report for the period ended September 27, 2014
11/05/2014 425 Form 425 - Prospectuses and communications, business combinations
11/04/2014 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition
10/30/2014 8-K Quarterly results
Docs: "Third Quarter Highlights:"
09/25/2014 SC 13G Moab Capital Partners LLC reports a 7.7% stake in SYMMETRY MEDICAL INC.
08/08/2014 8-K Asset disposition
Docs: "Consent of Ernst & Young LLP",
"Updated Financial Information to the Company's 2013 Form 10-K"
08/07/2014 10-Q Quarterly Report for the period ended June 28, 2014
08/04/2014 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger",
"Separation Agreement"
08/04/2014 425 Form 425 - Prospectuses and communications, business combinations
08/04/2014 8-K Quarterly results
Docs: "Second Quarter Highlights:"
08/04/2014 8-K Investor presentation
Docs: "Symmetry Surgical to Become a New Standalone Public Company",
"Investor Presentation Symmetry Medical, Inc."
08/04/2014 425 Form 425 - Prospectuses and communications, business combinations
05/28/2014 8-K Asset disposition
Docs: "The Share Purchase Agreement entered into by and between Symmetry Medical Sheffield, Ltd., Symmetry Medical Switzerland, S.A. and The HLD Corporation Limited",
"As Adjusted Non-GAAP Measures",
"Unaudited pro forma consolidated financial statements of Symmetry Medical Inc. as of and for the three months ended March 29, 2014 and for the years ended December 28, 2013, December 29, 2012 and December 31, 2011 and the notes related thereto"
05/02/2014 10-Q Quarterly Report for the period ended March 29, 2014
05/01/2014 8-K Quarterly results
Docs: "Reiterates 2014 Financial Guidance"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy